Summit Therapeutics Inc. Quarterly Interest Expense in USD from Q2 2021 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Summit Therapeutics Inc. quarterly/annual Interest Expense history and growth rate from Q2 2021 to Q1 2023.
  • Summit Therapeutics Inc. Interest Expense for the quarter ending March 31, 2023 was $8.33M, a 5378% increase year-over-year.
  • Summit Therapeutics Inc. Interest Expense for the twelve months ending March 31, 2023 was $12.6M.
  • Summit Therapeutics Inc. annual Interest Expense for 2022 was $4.4M, a 1719% increase from 2021.
  • Summit Therapeutics Inc. annual Interest Expense for 2021 was $242K, a 5.1% decline from 2020.
  • Summit Therapeutics Inc. annual Interest Expense for 2020 was $255K, a 12.4% decline from 2019.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $12.6M $8.33M +$8.18M +5378% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $4.4M $2.9M Oct 1, 2022 Dec 31, 2022 10-K 2023-03-09
Q3 2022 $692K +$692K Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $653K +$437K +202% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $152K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q3 2021 $0 Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $216K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.